Choline Salicylate/ Cetalkonium Chloride
Indications
Registered South African indications:
- Pain
- Inflammation
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Active peptic ulceration
- Salicylate sensitivity
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Children younger than 16 years
Adult dosage
Forms avail. in SA and covered in this monograph: gel
Pain and inflammation of the mouth (common mouth ulcers, cold sores, sore spots, dentures or orthodontic devices)
- Topical (gel): Apply about 1cm to the tender area, 6-8hrly and at bedtime
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: gel
Pain and inflammation of the mouth (common mouth ulcers, cold sores, sore spots, dentures, orthodontic devices and teething)
Younger than 2 years
- Topical (gel): Apply about 0.5cm to the tender area, 6-8hrly and at bedtime
Older than 2 years
- Topical (gel): Apply about 1cm to the tender area, 6-8hrly and at bedtime
Dosage represented above is from the SA approved Package insert (1979). Later international summary product characteristics (2015) note the following: ''Not to be used in children and adolescents under the age of 16. This is because there is a possible association between salicylates and Reye's syndrome when given to children''
Special populations
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Drugs in Sport
- Permitted - No warning
Adverse reactions
Respiratory Disorders
- Bronchospasm
- Asthma
Others
- Slight tingling after application
Interactions
- Anticoagulants
- Uricosurics
Monitoring
None routine
Mechanism of action
Choline salicylate inhibits prostaglandin production. It may also have effects on leukotriene pathways, kinin release and nerve conduction. Cetalkonium chloride is an antimicrobial agent which is bactericidal towards both Gram positive and Gram negative organisms.
Dosage forms
- Gel
Formulation
COMBINATION PREPARATIONS
Choline salicylate/ Cetalkonium chloride
Gel (per mg) 87.1%/0.1%
- Bonjela (Reckitt Benckisser)
- Teejel (Adcock)
References
1. SmPC: Bonjela Jel, Reckitt Benckiser Healthcare (UK) Ltd:Last updated on eMC: 20 Apr 2018; Downloaded online 30 Nov 2018 [https://drive.google.com/drive/u/0/folders/15KFbM7C_Dh6hXiWK-gowZc-gNJHyhaym] [https://www.medicines.org.uk/emc/medicine/23327] 2. PI: TeeJel gel, Adcock Ingram Ltd:Date of registration: 2 Oct 1979 [https://drive.google.com/drive/u/0/folders/15KFbM7C_Dh6hXiWK-gowZc-gNJHyhaym] 3. SAMF_Page 35
Brands & products
0 products · cached snapshot- Bonjela
- Teejel
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.